CD44 and its V6 spliced variant in lung carcinomas: Relation to NCAM, CEA, EMA and UP1 and prognostic significance

0173311 - UEM-P 20003033 RIV SK eng J - Článek v odborném periodiku
Nguyen, V. N. - Miřejovský, T. - Mandys, Václav
CD44 and its V6 spliced variant in lung carcinomas: Relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Neoplasma. Roč. 47, č. 6 (2000), s. 400-408. ISSN 0028-2685. E-ISSN 1338-4317
Grant CEP: GA MZd IZ4187
Výzkumný záměr: CEZ:AV0Z5039906
Kód oboru RIV: EA - Morfologické obory a cytologie
Impakt faktor: 0.579, rok: 2000

The data of this study suggest that CD44v6 might be an independent prognostic factor in NSCLC.
Trvalý link: http://hdl.handle.net/11104/0070346